IP Library › Patent Application 62005492
Patent Application Provisional
App. No. 62/005,492 · Confirmation No. 5855

TREATMENT OF CHRONIC NEUTROPHILIC LEUKEMIA (CNL) AND ATYPICAL CHRONIC MYELOID LEUKEMIA (aCML) BY INHIBITORS OF JAK1

Applicant: Incyte Corporation
Provisional Application Expired
⬇ PDF
 Code Description Pages PDF
2015-01-09 APP.FILE.REC Filing Receipt 3 View
2015-01-07 R48.REQ Request under Rule 48 correcting inventorship 1 View
2015-01-07 ADS Application Data Sheet 2 View
2015-01-07 WFEE Fee Worksheet (SB06) 2 View
2015-01-07 N417 Electronic Filing System Acknowledgment Receipt 2 View
2014-11-14 ADS Application Data Sheet 2 View
2014-11-14 N417 Electronic Filing System Acknowledgment Receipt 2 View
2014-06-16 APP.FILE.REC Filing Receipt 3 View
2014-05-30 TR.PROV Provisional Cover Sheet (SB16) 1 View
2014-05-30 ADS Application Data Sheet 7 View
2014-05-30 SPEC Specification 46 View
2014-05-30 CLM Claims 4 View
2014-05-30 ABST Abstract 1 View
2014-05-30 WFEE Fee Worksheet (SB06) 2 View
2014-05-30 N417 Electronic Filing System Acknowledgment Receipt 3 View
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this application's details
Quick Facts
App. No.
62/005,492
Filed
2014-05-30